EUVIMEDEUVIMED entdecken
Systematische ÜbersichtNetzwerk-MetaanalyseVergleichsstudieOpen Access · CC BY-NC-ND 4.0

Comparison of polidocanol endovenous microfoam (Varithena) to physician-compounded foam in sclerotherapy treatment of truncal varicosities: A systematic review and network meta-analysis

Runzhi Chen, Chien Lin Soh, Marwah Salih, Matthew Tan, Benedict Turner, Sarah Onida, Alun H Davies

Journal of Vascular Surgery: Venous and Lymphatic Disorders · 2026-07 · 14 (4) · 102460

DOI: 10.1016/j.jvsv.2026.102460 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Vascular Surgery: Venous and Lymphatic Disorders, 2026-07. Verfasst von Runzhi Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Section of Vascular Surgery, Department of Surgery and Cancer, Imperial College London, London, UK. Hauptthemen laut MEDLINE: Polidocanol, Sclerotherapy, Varicose Veins, Sclerosing Solutions. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Commercial premixed foam sclerosants such as Varithena, a polidocanol endovenous microfoam, have been developed and marketed as better alternatives to physician-compounded foams (PCFs). The aim of this study was to evaluate the efficacy of Varithena compared with PCFs in foam sclerotherapy for the treatment of truncal varicose veins. METHODS: A systematic review was performed according to PRISMA and Meta-Analysis guidelines with a registered protocol (PROSPERO: CRD42024494805) using Medline and EMBASE databases from inception to June 17, 2025, by two reviewers. Randomized controlled trials that reported on occlusion rates after truncal varicose vein treatment with foam sclerotherapy were included. A network meta-analysis was performed. RESULTS: Six randomized controlled trials with a total of 1726 patients were identified. Complete occlusion was defined as elimination of saphenofemoral junction reflux or occlusion of the saphenous vein on duplex imaging. The median follow-up was 39 weeks (range, 12-52 weeks). No significant difference was observed between Varithena and PCF with respect to occlusion rates at follow-up (risk ratio [RR], 1.12; 95% confidence interval [CI], 0.93-1.35; I2 =71%). Moreover, similar rates of adverse events were observed between the Varithena and PCF groups (RR, 2.89; 95% CI, 0.64-12.97; I2 = 0%). Compared to foam sclerotherapy, surgical removal and endovenous laser ablation showed a significantly higher occlusion rate at follow-up (RR 1.32, 95% CI 1.18-1.47, I2=71% and RR 1.33, 95% CI 1.18-1.49, I2=71%, respectively). CONCLUSIONS: In patients with saphenous varices, there was no indication that Varithena was superior to or associated with fewer complications than PCFs Further trials are required to define the role of Varithena in the treatment of varicose veins, especially within the context of less expensive alternatives.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PolidocanolSclerotherapyVaricose VeinsSclerosing SolutionsHumansTreatment OutcomeSaphenous VeinRandomized Controlled Trials as TopicMaleFemale

Stichwörter der Autor:innen

Chronic venous diseaseFoam sclerotherapyPhysician-compounded foamPolidocanolVaricose veinsVarithena

Substanzen

PolidocanolSclerosing Solutions

Autor:innen und Institutionen

  • Section of Vascular Surgery, Department of Surgery and Cancer, Imperial College London, London, UK.
  • Section of Vascular Surgery, Department of Surgery and Cancer, Imperial College London, London, UK. Electronic address: matthew.tan13@imperial.ac.uk.

Förderung

  • NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research

Zitieren

APA

Chen, R., Soh, C. L., Salih, M., Tan, M., Turner, B., Onida, S., & Davies, A. H. (2026). Comparison of polidocanol endovenous microfoam (Varithena) to physician-compounded foam in sclerotherapy treatment of truncal varicosities: A systematic review and network meta-analysis. Journal of Vascular Surgery: Venous and Lymphatic Disorders, 14(4), 102460. https://doi.org/10.1016/j.jvsv.2026.102460

Vancouver

Chen R, Soh CL, Salih M, Tan M, Turner B, Onida S, et al. Comparison of polidocanol endovenous microfoam (Varithena) to physician-compounded foam in sclerotherapy treatment of truncal varicosities: A systematic review and network meta-analysis. Journal of Vascular Surgery: Venous and Lymphatic Disorders. 2026;14(4):102460. doi:10.1016/j.jvsv.2026.102460

BibTeX
@article{Chen2026,
  author = {Chen, Runzhi and Soh, Chien Lin and Salih, Marwah and Tan, Matthew and Turner, Benedict and Onida, Sarah and Davies, Alun H},
  title = {Comparison of polidocanol endovenous microfoam (Varithena) to physician-compounded foam in sclerotherapy treatment of truncal varicosities: A systematic review and network meta-analysis},
  journal = {Journal of Vascular Surgery: Venous and Lymphatic Disorders},
  year = {2026},
  volume = {14},
  number = {4},
  pages = {102460},
  doi = {10.1016/j.jvsv.2026.102460}
}
Kostenlos starten →